Skip to main content

Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 706–720 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3664
STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test

This genetic test evaluates the STAR gene for pathogenic variants associated with Lipoid Congenital Adrenal Hyperplasia (LCAH). It identifies mutations causing adrenal insufficienc...

Whole Blood (Peripheral) or DNA Extract 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the STAR gene", "Copy Number Variations (CNV) in the STAR gene"]
Parameters
[]
Preparation
["Genetic counseling is mandatory before testing", "Fasting is not required"]
Indications
["Suspected Lipoid Congenital Adrenal Hyperplasia (LCAH)", "Neonatal screening for endocrine disorders", "Family history of LCAH", "Evaluation of adrenal insufficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82377-1 ICD-10: E25.0
Clinical summary
This genetic test evaluates the STAR gene for pathogenic variants associated with Lipoid Congenital Adrenal Hyperplasia (LCAH). It identifies mutations causing adrenal insufficiency and sex hormone deficiency.
TEST-5382
STAT1 Gene Atypical Mycobacterial Infection Genetic Test

This genetic test analyzes the STAT1 gene for mutations associated with an increased risk of developing severe infections caused by atypical mycobacteria.

Peripheral blood (2 mL EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["STAT1 gene coding region variants", "STAT1 gene splice site variants", "STAT1 gene copy number variations"]
Parameters
[{"name": "STAT1 Gene Analysis", "reference_range": "No pathogenic variants detected"}]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Diagnosis of Mendelian susceptibility to mycobacterial disease (MSMD)", "Identification of STAT1 gene mutations in individuals with recurrent atypical mycobacterial infections", "Carrier screening in families with a known history of STAT1 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100398-6 ICD-10: D84.8
Clinical summary
This genetic test analyzes the STAT1 gene for mutations associated with an increased risk of developing severe infections caused by atypical mycobacteria.
TEST-5015
STAT3 Gene Hyper‑IgE Syndrome Genetic Test

This test evaluates the STAT3 gene for pathogenic variants associated with Autosomal Dominant Hyper-IgE Syndrome (AD-HIES).

Whole blood (EDTA), extracted DNA, or FTA card blood spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["STAT3 gene sequence", "Pathogenic variants in STAT3"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Clinical suspicion of Autosomal Dominant Hyper-IgE Syndrome (AD-HIES)", "Recurrent infections", "Eczema", "Skeletal abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101501-7 ICD-10: D82.4, Z15.89, Z82.79
Clinical summary
This test evaluates the STAT3 gene for pathogenic variants associated with Autosomal Dominant Hyper-IgE Syndrome (AD-HIES).
TEST-4273
STXBP1 Gene (Early Infantile Epileptic Encephalopathy Type 4) Genetic Test

This test identifies pathogenic mutations in the STXBP1 gene associated with early infantile epileptic encephalopathy type 4 (EIEE4). It uses Next-Generation Sequencing (NGS) with...

Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card Dried Blood Spot 3–4 weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["STXBP1 gene coding region", "STXBP1 gene splice-site boundaries"]
Parameters
[]
Preparation
["No fasting or special dietary preparation is needed.", "Mandatory pre-test genetic counselling session must be completed before sample collection."]
Indications
["Diagnosis of early infantile epileptic encephalopathy type 4 (EIEE4)", "Identification of pathogenic STXBP1 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94058-8 ICD-10: G40.4
Clinical summary
This test identifies pathogenic mutations in the STXBP1 gene associated with early infantile epileptic encephalopathy type 4 (EIEE4). It uses Next-Generation Sequencing (NGS) with Sanger confirmation for clinically actionable variants.
TEST-6392
SUGCT Gene Glutaric Aciduria Type 3 Genetic Test

This genetic test identifies pathogenic variants in the SUGCT gene, confirming a diagnosis of glutaric aciduria type 3.

Peripheral Whole Blood (3–5 mL in EDTA tube); alternative: buccal swab for neonates 3–4 Weeks (expedited reporting for critically ill neonates) 2,800.00 AED
View
View test specifications and preparation
What it measures
["SUGCT gene sequence", "Pathogenic variants (point mutations, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting a specialist"]
Indications
["Suspected glutaric aciduria type 3", "Family history of glutaric aciduria type 3", "Inconclusive biochemical screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-3 ICD-10: E72.52
Clinical summary
This genetic test identifies pathogenic variants in the SUGCT gene, confirming a diagnosis of glutaric aciduria type 3.
TEST-3575
SULT2A1 Gene Polycystic Ovary Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the SULT2A1 gene associated with type 1 Polycystic Ovary Syndrome (PCOS). It uses Next-Generation Sequencing (NGS) to detect mutations l...

Peripheral whole blood (also accepted: extracted DNA, FTA card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SULT2A1 gene variants", "Pathogenic mutations associated with PCOS"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet changes needed"]
Indications
["Diagnosis of type 1 PCOS", "Familial risk assessment for PCOS", "Fertility planning", "Guiding precision therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86727-5 ICD-10: E28.2
Clinical summary
This test identifies pathogenic variants in the SULT2A1 gene associated with type 1 Polycystic Ovary Syndrome (PCOS). It uses Next-Generation Sequencing (NGS) to detect mutations linked to hyperandrogenism.
TEST-5904
SYNE1 Gene Spinocerebellar Ataxia Type 8 (Autosomal Recessive) Genetic Test

This genetic test identifies pathogenic variants in the SYNE1 gene associated with autosomal recessive spinocerebellar ataxia type 8 (SCAR8).

Peripheral Whole Blood or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SYNE1 gene", "Coding region and splice sites coverage"]
Parameters
[]
Preparation
["No fasting required", "Bring valid Emirates ID, insurance card, and completed genetic counselling referral form", "Avoid heavy muscular exertion immediately before collection"]
Indications
["Suspected diagnosis of Spinocerebellar Ataxia Type 8 (SCAR8)", "Family history of SCAR8", "Progressive neurological symptoms consistent with SCAR8"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83511-4 ICD-10: G11.8, R27.0
Clinical summary
This genetic test identifies pathogenic variants in the SYNE1 gene associated with autosomal recessive spinocerebellar ataxia type 8 (SCAR8).
TEST-4224
TAB2 Gene (Congenital Heart Defects, Multiple Types) Genetic Test

This genetic test evaluates the TAB2 gene for pathogenic variants associated with multiple types of congenital heart defects.

Peripheral Blood (Whole Blood) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TAB2 gene", "Single nucleotide variants (SNVs)", "Insertions", "Deletions", "Copy number variants"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counselling is mandatory"]
Indications
["Diagnosis of congenital heart defects", "Risk assessment for family members", "Informed family planning", "Correlation with echocardiographic findings"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q24.9
Clinical summary
This genetic test evaluates the TAB2 gene for pathogenic variants associated with multiple types of congenital heart defects.
TEST-4748
TACO1 Gene Analysis for Leigh Syndrome (Mitochondrial Complex IV Deficiency) Test

This test identifies pathogenic variants in the TACO1 gene, a known cause of Leigh syndrome associated with mitochondrial complex IV deficiency.

Whole blood (EDTA tube), extracted DNA, dried blood spot (FTA card) 21–28 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["TACO1 gene sequence", "Point mutations", "Small insertions/deletions", "Canonical splice-site variants"]
Parameters
[]
Preparation
["Inform clinician of all current medications, dietary supplements.", "Inform clinician of any organ transplantation or blood transfusion within the preceding two weeks."]
Indications
["Suspected Leigh Syndrome", "Mitochondrial Complex IV Deficiency", "Family history of Leigh Syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94872-0 ICD-10: E88.41
Clinical summary
This test identifies pathogenic variants in the TACO1 gene, a known cause of Leigh syndrome associated with mitochondrial complex IV deficiency.
TEST-3720
TACR3 Gene Hypogonadotropic Hypogonadism Type 11 Genetic Test

This diagnostic test evaluates the TACR3 gene for mutations associated with congenital hypogonadotropic hypogonadism type 11.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TACR3 gene", "Coding exons, intronic boundaries, and known regulatory regions"]
Parameters
[]
Preparation
["No special preparation or fasting required", "Inform phlebotomist of current medications"]
Indications
["Delayed puberty", "Anosmia", "Unexplained infertility", "Family history of hypogonadotropic hypogonadism"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81265-7 ICD-10: E23.0
Clinical summary
This diagnostic test evaluates the TACR3 gene for mutations associated with congenital hypogonadotropic hypogonadism type 11.
TEST-4873
TAF2 Gene MRT40 Genetic Test

This test identifies pathogenic variants in the TAF2 gene associated with autosomal recessive mental retardation type 40 (MRT40).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TAF2 gene exons and splice sites"]
Parameters
[]
Preparation
[]
Indications
["Suspected MRT40", "Confirmatory testing for intellectual disability", "Targeted family screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82306-7 ICD-10: F70, F79
Clinical summary
This test identifies pathogenic variants in the TAF2 gene associated with autosomal recessive mental retardation type 40 (MRT40).
TEST-1089
Targeted Mutation Analysis (1 Mutation) Test

This test identifies the presence or absence of a single, pre-specified genetic mutation using Sanger sequencing.

Peripheral whole blood (EDTA or ACD tube) 10–15 working days 1,200.00 AED
View
View test specifications and preparation
What it measures
["Specific DNA sequence variant"]
Parameters
[]
Preparation
["Inform healthcare provider about all medications, supplements, or herbal products"]
Indications
["Diagnosis of hereditary conditions", "Risk assessment for genetic disorders", "Personalized management of genetic conditions", "Known familial mutation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 84452-4 ICD-10: Z13.79
Clinical summary
This test identifies the presence or absence of a single, pre-specified genetic mutation using Sanger sequencing.
TEST-6152
TARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 21 Genetic Test

This genetic test identifies pathogenic variants in the TARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 21.

Whole Blood (EDTA), Extracted DNA, or Buccal Swab (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TARS2 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of all medications and supplements"]
Indications
["Suspected Combined Oxidative Phosphorylation Deficiency Type 21", "Family screening for TARS2 variants"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88883-9 ICD-10: E88.49
Clinical summary
This genetic test identifies pathogenic variants in the TARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 21.
TEST-4410
TBC1D24 Gene Familial Infantile Myoclonic Epilepsy Genetic Test

This test detects pathogenic variants in the TBC1D24 gene associated with familial infantile myoclonic epilepsy.

Peripheral Whole Blood (EDTA tube) or FTA Card Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBC1D24 gene", "Synaptic vesicle trafficking protein alterations"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory", "Document family history and construct a three-generation pedigree"]
Indications
["Suspected familial infantile myoclonic epilepsy", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94037-1 ICD-10: G40.4
Clinical summary
This test detects pathogenic variants in the TBC1D24 gene associated with familial infantile myoclonic epilepsy.
TEST-4563
TBR1 Gene Genetic Test for Intellectual Disability

This test identifies pathogenic variants within the TBR1 gene using Next-Generation Sequencing (NGS). It is used to diagnose TBR1-related neurodevelopmental disorders.

Whole Blood, Extracted DNA, FTA Card (dried blood spot) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBR1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of TBR1-related neurodevelopmental disorders", "Genetic clarification for intellectual disability", "Evaluation of autism spectrum disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82370-6 ICD-10: F78.9
Clinical summary
This test identifies pathogenic variants within the TBR1 gene using Next-Generation Sequencing (NGS). It is used to diagnose TBR1-related neurodevelopmental disorders.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.